Wang, Cuiyan
Zhang, Yueqian
Lim, Lam Ghai
Cao, Weiqi
Zhang, Wei
Wan, Xiaoyang
Fan, Lijun
Liu, Ying
Zhang, Xi
Tian, Zengjie
Liu, Xiaojun
Pan, Xiuzhi
Zheng, Yuan
Pan, Riyu
Tan, Yilin
Zhang, Zhisong
McIntyre, Roger S.
Li, Zhifei
Ho, Roger C. M.
Tang, Tong Boon
Funding for this research was provided by:
Anhui Engineering Research Center for Intelligent Computing and Application on Cognitive Behavior
Monash University Malaysia (School of Engineering Internal Seed Grant SED-000103)
Humanities and Social Science Research Project at Anhui University (SK2021ZD0047)
National University of Singapore (NUS) Department of Psychological Medicine (R-177-000-100-001/R-177-000-003-001/R177000702733)
NUS iHealthtech Other Operating Expenses (R-722-000-004-731)
UTP Centre for Intelligent Signal and Imaging Research
Article History
Received: 24 October 2022
Accepted: 2 July 2023
First Online: 10 July 2023
Competing interests
: Dr. Roger McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute; speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences. Dr. Roger McIntyre is a CEO of Braxia Scientific Corp. All other authors declare no competing interests.